HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
Quote | HUTCHMED (China) Limited (NASDAQ:HCM)
Last: | $15.97 |
---|---|
Change Percent: | 1.84% |
Open: | $16 |
Close: | $15.97 |
High: | $16.085 |
Low: | $15.97 |
Volume: | 19,042 |
Last Trade Date Time: | 07/10/2025 03:29:36 pm |
News | HUTCHMED (China) Limited (NASDAQ:HCM)
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Ti...
Correlate Energy Corp. (CIPI) is expected to report for quarter end 2025-03-31 EssilorLuxottica ADR (ESLOY) is expected to report for Q1 2025 Novaccess Global Inc (XSNX) is expected to report for quarter end 2025-03-31 Gear Energy Ltd (GENGF) is expected to report for Q1 2025 Dong...
Message Board Posts | HUTCHMED (China) Limited (NASDAQ:HCM)
Subject | By | Source | When |
---|---|---|---|
The now last up | MWM | investorshub | 05/10/2023 3:35:25 PM |
$HCM Time for this to show some returns | MWM | investorshub | 05/08/2023 7:41:07 PM |
$HCM MomentumIts gaining | crowin | investorshub | 05/08/2023 7:12:07 AM |
short squeeze | MWM | investorshub | 05/08/2023 1:11:22 AM |
$HCM The trading last up | MWM | investorshub | 05/07/2023 6:33:31 AM |
News, Short Squeeze, Breakout and More Instantly...
HUTCHMED (China) Limited Company Name:
HCM Stock Symbol:
NASDAQ Market:
1.84% G/L:
$15.97 Last:
19,042 Volume:
$16 Open:
$15.97 Close:
HUTCHMED (China) Limited Website:
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Ti...
Correlate Energy Corp. (CIPI) is expected to report for quarter end 2025-03-31 EssilorLuxottica ADR (ESLOY) is expected to report for Q1 2025 Novaccess Global Inc (XSNX) is expected to report for quarter end 2025-03-31 Gear Energy Ltd (GENGF) is expected to report for Q1 2025 Dong...
— Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy — — The only all-oral combination treatment option for these patients — —...